OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
September 10, 2009
Company and People Notes: Neoprobe and Laureate Pharma form manufacturing agreement; Akela Pharma appoints CEO and chairman; more...
September 03, 2009
The US Pharmacopeial Convention (USP) and the Permanent Commission of the Pharmacopeia of the United Mexican States (FEUM) signed a memorandum of understanding (MOU) last week.
Also, Orexo and Novartis form agreement; Affitech appoints Robert Burns CEO; more...
September 02, 2009
Brief pharmaceutical news items for September 2009.
After years of promomting QbD concepts, FDA's ready to take action on nonconformers.
Contract-service providers are expanding their offerings in this slow-growth environment.
Personalized medicine and integrated healthcare delivery require new business and pricing models. This article contains bonus online-exclusive material.
Select contract manufacturing organizations roll out expansions for production of active pharmaceutical ingredients and intermediates.
As new process validation guidelines emerge, industry needs to reinvent how it releases product.
IPEC's new stability testing guide takes into account the full supply chain's storage conditions.